Role of Natural Killer cells in the pathogenesis of Primary Biliary Cholangitis
Primary biliary cholangitis (PBC) is a chronic liver disease characterized by progressive destruction of intra-hepatic bile ducts associated with immune dysregulation.
Although the adaptive immune response has long been involved in PBC pathogenesis, increasing evidence suggests that also innate immune cells may play an active role in the disease. In particular, natural killer (NK) cells are increased in the liver of PBC patients and could play a role in the destruction of biliary epithelial cells (BECs).
In this project, we aim to investigate the pathogenic role of NK cells and characterize the mechanisms of NK cell-mediated BEC destruction in PBC, taking advantage of multicolor flow cytometry and NGS techniques.
TEAM
Silvia Della Bella MD, PhD - Senior staff scientist
Simone Balin - PhD student
Paolo Marzano - PhD student, bioinformatician
Annalisa Imperiali - PhD student, bioinformatician
Joanna Mikulak PhD - Senior staff scientist
Valentina Cazzetta - Post-doctoral fellow
FUNDING
Ministero della Salute
Ricerca Finalizzata
collaborations
Division of Internal Medicine and Hepatology
Department of Gastroenterology
IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
Hepatobiliary Immunopathology Laboratory
IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
Department of Biomedical Sciences
Humanitas University, Pieve Emanuele, Milan, Italy
Department of Medicine and Surgery
University of Milano-Bicocca, Milan, Italy
Division of Gastroenterology
Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
Division of General Surgery and Transplantation
Department of Transplantation
ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
Institute of Genetic and Biomedical Research
National Research Council of Italy, Milan, Italy
related publications
Natural Killer-Dendritic Cell Interactions in Liver Cancer: Implications for Immunotherapy
Cazzetta V, Franzese S, Carenza C, Della Bella S, Mikulak J, Mavilio D.
Cancers (Basel). 2021 May 1;13(9):2184. doi: 10.3390/cancers13092184.